Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01698658 · ClinicalTrials.gov registry record · NA

Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer

A NA study, sponsored by Barbara Ann Karmanos Cancer Institute.

Completed
Registry status
NA
Development phase
657
Enrollment target

NCT01698658: Completed NA study, sponsored by Barbara Ann Karmanos Cancer Institute.

NCT01698658 is a NA study that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 657 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01698658, a NA study, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.

COMPLETED
Registry status
NA
Development phase
657 participants
Enrollment target

Study Summary

This clinical trial studies ultrasound tomography using SoftVue in diagnosing women with breast cancer. New diagnostic procedures, such as ultrasound tomography using SoftVue, may help find and diagnose breast cancer.

Primary Outcome

For each type of resolution, observed values will be averaged over slices for each participant and compared to milestone values. The proportion of individuals whose images meet the milestone criteria will be reported with 95% confidence intervals calculated using Wilson's method.

Interventions

  • PROCEDURE magnetic resonance imaging
  • OTHER ultrasound tomography

Trial Details

FieldValue
Enrollment Target 657 participants
Start Date 2012-10
Est. Completion 2018-11-16
Phase NA

What the finished NCT01698658 record still lists

NCT01698658 is an interventional study that assigns participants to a tested intervention. The registered 657 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).

The record links to 0 conditions, and to 2 interventions - of which magnetic resonance imaging is the first listed.

NCT01698658 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01698658 about?

NCT01698658 is a clinical study titled "Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer". This clinical trial studies ultrasound tomography using SoftVue in diagnosing women with breast cancer. New diagnostic procedures, such as ultrasound tomography using SoftVue, may help find and diagnose breast cancer.

What is the current status of trial NCT01698658?

This trial is currently completed. It is a NA study. The enrollment target is 657 participants. The study started on 2012-10. Estimated completion is 2018-11-16.

What interventions are being tested in trial NCT01698658?

The interventions under investigation include: magnetic resonance imaging (PROCEDURE), ultrasound tomography (OTHER).

Who is sponsoring clinical trial NCT01698658?

This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01698658's enrollment target sits among peer trials

657 156th of 2000 higher than 1,845 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03671044 · 657 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

  • NCT05338697 · 657 participants

    Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

  • NCT05407129 · 656 participants · NA

    Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

  • NCT06127199 · 656 participants · NA

    Contraceptive Efficacy Study of Ovaprene

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01698658, the US trial registry maintained by the National Library of Medicine. NCT01698658 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.